To include your compound in the COVID-19 Resource Center, submit it here.

Forest Laboratories generics, pharmaceuticals news

Forest and activist investor Carl Icahn issued dueling SEC filings last week arguing in favor of their

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE